aceclofenac has been researched along with piroxicam in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| de Buergo, M; Montull Fruitós, E; Rico Lenza, H; Villa Alcázar, LF | 1 |
| Alonso-Ruiz, A; Ansoleaga, JJ; Perez-Ruiz, F | 1 |
| Alepuz Pou, M; Bermudez, A; Calero, E; Caliz, R; Cano, M; Caracuel, MA; Castellon Arce, P; Ffernandez Crisostomos, C; Garcia Lopez, A; Garcia Perez, S; Garcia Villalba, F; Garcia, C; Gines Martinez, F; Gonzalez, A; Gonzalez, J; Guzman Ubeda, M; Linares, LF; Lopez, MA; Marenco de la Fuente, IL; Mesa, J; Peréz Busquier, M; Povedano, A; Rodríguez, M; Roldan, R; Valenzuela, A | 1 |
| Blanco, FJ; Fernández-Sueiro, JL; Galdo, F; Lema, B; López-Armada, MJ; Maneiro, E | 1 |
| Acuña, JA; Sánchez-Batanero, P; Tascón, ML; Vázquez, MD | 1 |
| Aletras, AJ; Andonopoulos, AP; Giannopoulou, E; Gouvousis, PA; Panagiotopoulos, E; Syggelos, SA | 1 |
| Gromova, OA; Putilina, MV; Rudakov, KV; Stakhovskaia, LV; Torshin, IY | 1 |
1 review(s) available for aceclofenac and piroxicam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for aceclofenac and piroxicam
| Article | Year |
|---|---|
Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Participation; Piroxicam; Placebos; Spondylitis, Ankylosing; Surveys and Questionnaires | 1996 |
Comparative study of the efficacy and safety of aceclofenac and tenoxicam in rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Piroxicam | 1996 |
Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Osteoarthritis; Pain Measurement; Piroxicam | 1997 |
7 other study(ies) available for aceclofenac and piroxicam
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cartilage, Articular; Cells, Cultured; Chondrocytes; Culture Media, Conditioned; Diclofenac; Dinoprostone; Dose-Response Relationship, Drug; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Humans; Insulin-Like Growth Factor I; Interleukin 1 Receptor Antagonist Protein; Lipopolysaccharides; Middle Aged; Nitric Oxide; Osteoarthritis, Knee; Piroxicam; Sialoglycoproteins; Tumor Necrosis Factor-alpha | 2001 |
Polarographic behaviour of Aceclofenac, Tenoxicam and Droxicam in a methanol-water mixture.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Methanol; Piroxicam; Polarography; Pyridines; Quality Control; Solubility; Water | 2004 |
In vitro effects of non-steroidal anti-inflammatory drugs on cytokine, prostanoid and matrix metalloproteinase production by interface membranes from loose hip or knee endoprostheses.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cytokines; Diclofenac; Dinoprostone; Female; Hip Prosthesis; Humans; Indomethacin; Knee Prosthesis; Matrix Metalloproteinases; Middle Aged; Piroxicam; Tissue Inhibitor of Metalloproteinases | 2007 |
[The chemoreactomic analysis of the central mechanisms of action of non-steroidal anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Ketoprofen; Opiate Alkaloids; Pain; Piroxicam | 2020 |